CW 008 is an agonist of the cAMP/PKA/CREB pathway, promoting osteogenic differentiation of bone marrow-derived mesenchymal stem cells (MSCs), inhibiting leptin secretion, and enhancing alkaline phosphatase (ALP) activity. It is also regarded as a PKA activator in experimental studies.